A-53930A and B, novel N-type Ca2+ channel blockers

被引:14
|
作者
Hisamoto, M
Inaoka, Y
Sakaida, Y
Kagazaki, T
Enokida, R
Okazaki, T
Haruyama, H
Kinoshita, T
Matsuda, K
机构
[1] Sankyo Co Ltd, Neurosci Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[2] Sankyo Co Ltd, Analyt & Metab Res Labs, Shinagawa Ku, Tokyo 1408710, Japan
[3] Sankyo Co Ltd, Biomed Res Labs, Iwaki, Fukushima 9718183, Japan
[4] Sankyo Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 3050841, Japan
来源
JOURNAL OF ANTIBIOTICS | 1998年 / 51卷 / 07期
关键词
D O I
10.7164/antibiotics.51.607
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A-53930A, B and C, which inhibit N-type Ca2+ channels, were isolated from the culture broth of Streptomyces vinaceusdrappus SANK 62394. A-53930A and B were new compounds which contained a carbamoyl group on the 6-hydroxyl group of the D-gulosamine part of streptothricin. A-53930C was identical to streptothricin B. A-53930A, B and C inhibited [I-125]omega-conotoxin MVIIA binding to N-type Ca2+ channels (IC50 = 0.17, 0.091 and 0.071 mu M), but did not inhibit [H-3]PN200-110 binding to L-type Ca2+ channels (IC50> 50 mu M). These compounds also inhibited [H-3]norepinephrine release from chick cerebral cortex synaptosomes (IC50 = 91.0, 20.6 and 39.5 mu M), indicating these compounds selectively block N-type Ca2+ channels which are important for neurotransmitter release. It was also revealed that although A-53930C had antimicrobial activity against Gram-negative and -positive bacteria and fungi, A-53930A and B showed weak activity only against Gram-negative bacteria.
引用
收藏
页码:607 / 617
页数:11
相关论文
共 50 条
  • [1] THE EFFECT OF N-TYPE CA2+ CHANNEL BLOCKERS ON [CA2+]I DYNAMICS IN SOMA AND DENDRITES OF DOPAMINERGIC-NEURONS
    DEERAUSQUIN, GA
    BROOKER, G
    HANBAUER, I
    FASEB JOURNAL, 1991, 5 (05): : A1102 - A1102
  • [2] Cloning and functional expression of novel N-type Ca2+ channel variants
    Lü, Q
    Dunlap, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) : 34566 - 34575
  • [3] Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca2+ channel blockers with analgesic activity
    Beebe, Xenia
    Darczak, Daria
    Henry, Rodger F.
    Vortherms, Timothy
    Janis, Richard
    Namovic, Marian
    Donnelly-Roberts, Diana
    Kage, Karen L.
    Surowy, Carol
    Milicic, Ivan
    Niforatos, Wende
    Swensen, Andrew
    Marsh, Kennan C.
    Wetter, Jill M.
    Franklin, Pamela
    Baker, Scott
    Zhong, Chengmin
    Simler, Gricelda
    Gomez, Erica
    Boyce-Rustay, Janel M.
    Zhu, Chang Z.
    Stewart, Andrew O.
    Jarvis, Michael F.
    Scott, Victoria E.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (13) : 4128 - 4139
  • [4] Non-L-type actions of organic Ca2+ channel blockers:: Implications for Na+ and N-type Ca2+ channels blockades
    Uneyama, H
    Uchida, H
    Maeda, K
    Yoshimoto, R
    Watanabe, Y
    Inoue, K
    CALCIUM ION MODULATORS: THE NEW WAVE OF PSYCHOTROPIC DRUGS, 1998, : 13 - 23
  • [5] Specific N-type Ca2+ channel potentiation and its mechanism by a novel drug
    Nakao, K
    Sugishita, A
    Shirakawa, H
    Kaneko, S
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2005, 125 : 38 - 39
  • [6] Novel series of pyrazolylpiperidine N-type calcium channel blockers
    Subasinghe, Nalin L.
    Wall, Mark
    Winters, Michael P.
    Qin, Ning
    Lubin, Mary L.
    Finley, Michael F.
    Brandt, Michael R.
    Neeper, Michael
    Schneider, Craig R.
    Colburn, Raymond
    Flores, Christopher M.
    Sui, Zhihua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [7] A novel series of pyrazolylpiperidine N-type calcium channel blockers
    Subasinghe, Nalin L.
    Wall, Mark J.
    Winters, Michael P.
    Qin, Ning
    Lubin, Mary Lou
    Finley, Michael F. A.
    Brandt, Michael R.
    Neeper, Michael P.
    Schneider, Craig R.
    Colburn, Raymond W.
    Flores, Christopher M.
    Sui, Zhihua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (12) : 4080 - 4083
  • [8] N-type calcium channel blockers
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1999, 4 (07) : 335 - 336
  • [9] N-type calcium channel blockers
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1999, 4 (01) : 39 - 39
  • [10] Comparison of L/N-Type Ca2+ channel blocker and L-Type Ca2+ channel blocker in migraine model rat
    Masuda, R.
    Koizumi, K.
    Yonekura, J.
    Kitamura, E.
    Hamada, J.
    CEPHALALGIA, 2009, 29 : 118 - 119